Keyphrases
Nanobody
100%
In Vitro Inhibition
100%
Cancer Cell Migration
100%
Cancer Angiogenesis
100%
Orphan Receptor
100%
Angiopoietin
50%
Non-immune
33%
Receptor Tyrosine Kinase
33%
Cell Viability
16%
Cell-based
16%
Cell Migration
16%
Therapeutic Potential
16%
Phosphorylation
16%
Endothelial Cells
16%
Nave
16%
Signaling Molecules
16%
Angiogenesis
16%
Therapeutic Intervention
16%
Low Expression
16%
Expression Stability
16%
High-level Expression
16%
Epitope
16%
Extracellular Domain
16%
Cancer-related
16%
Glioblastoma Cell Lines
16%
Pathophysiological Roles
16%
Putative Targets
16%
Preferential Binding
16%
Tie-2 Receptor
16%
Selective Inhibitor
16%
Highest Good
16%
Immune Antibody Library
16%
Antibody Library Screen
16%
Synthetic Nanobody
16%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
100%
Single-Domain Antibody
100%
Orphan Receptor
100%
Angiopoietin 1
42%
Receptor Tyrosine Kinase
28%
Surface Property
14%
Cell Viability
14%
Monospecific Antibody
14%
Cell Migration
14%
Angiopoietin Receptor
14%
Antibody Library
14%
Immunology and Microbiology
Angiogenesis
100%
Single-Domain Antibody
100%
Angiopoietin 1
42%
Monospecific Antibody
14%
Surface Property
14%
Cell Migration
14%
Epitope
14%
Cell Viability
14%
Antibody Library
14%